Several studies suggested that PD-L1 was highly expressed in EGFR wildtype NSCLC [35, 36]; meanwhile, a negative or no correlation between EGFR mutation and PD-L1 expression was also concluded [37–39]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.